{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:30Z","timestamp":1791413370964,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010041","name":"Tianjin Science and Technology Committee","doi-asserted-by":"publisher","award":["H2018206600"],"award-info":[{"award-number":["H2018206600"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Science and Technology Committee","doi-asserted-by":"publisher","award":["18PTZWHZ00100"],"award-info":[{"award-number":["18PTZWHZ00100"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2018ZX09201015"],"award-info":[{"award-number":["2018ZX09201015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12149-021-01688-3","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T05:03:59Z","timestamp":1635570239000},"page":"172-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Prediction of HER2 expression in breast cancer by combining PET\/CT radiomic analysis and machine learning"],"prefix":"10.1007","volume":"36","author":[{"given":"Yiwen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiao","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3351-5695","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"key":"1688_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5:66.","journal-title":"Nat Rev Dis Primers"},{"key":"1688_CR2","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1056\/NEJMp058197","volume":"353","author":"HJ Burstein","year":"2005","unstructured":"Burstein HJ. The distinctive nature of HER2-positive breast cancers. N Engl J Med. 2005;353:1652\u20134.","journal-title":"N Engl J Med"},{"key":"1688_CR3","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"MJ Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353:1659\u201372.","journal-title":"N Engl J Med"},{"key":"1688_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science. 1987;235:177\u201382.","journal-title":"Science"},{"key":"1688_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-018-4956-y","volume":"173","author":"JX Ren","year":"2019","unstructured":"Ren JX, Gong Y, Ling H, Hu X, Shao ZM. Racial\/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res Treat. 2019;173:225\u201337.","journal-title":"Breast Cancer Res Treat"},{"key":"1688_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288\u2013300.","journal-title":"JAMA"},{"key":"1688_CR7","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1002\/cncr.24574","volume":"115","author":"KA Phillips","year":"2009","unstructured":"Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, et al. Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer. 2009;115:5166\u201374.","journal-title":"Cancer"},{"key":"1688_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11307-009-0294-0","volume":"12","author":"J Tchou","year":"2010","unstructured":"Tchou J, Sonnad SS, Bergey MR, Basu S, Tomaszewski J, Alavi A, et al. Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancer. Mol Imaging Biol. 2010;12:657\u201362.","journal-title":"Mol Imaging Biol"},{"key":"1688_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2017.02.037","volume":"175","author":"N Dey","year":"2017","unstructured":"Dey N, De P, Leyland-Jones B. PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials. Pharmacol Ther. 2017;175:91\u2013106.","journal-title":"Pharmacol Ther"},{"key":"1688_CR10","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1039\/C5MB00101C","volume":"11","author":"T Ersahin","year":"2015","unstructured":"Ersahin T, Tuncbag N, Cetin-Atalay R. The PI3K\/AKT\/mTOR interactive pathway. Mol Biosyst. 2015;11:1946\u201354.","journal-title":"Mol Biosyst"},{"key":"1688_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5152\/dir.2018.17367","volume":"24","author":"W Chen","year":"2018","unstructured":"Chen W, Zhu L, Yu X, Fu Q, Xu W, Wang P. Quantitative assessment of metabolic tumor burden in molecular subtypes of primary breast cancer with FDG PET\/CT. Diagn Interv Radiol. 2018;24:336\u201341.","journal-title":"Diagn Interv Radiol"},{"key":"1688_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00259-017-3770-9","volume":"44","author":"L Antunovic","year":"2017","unstructured":"Antunovic L, Gallivanone F, Sollini M, Sagona A, Invento A, Manfrinato G, et al. [(18)F]FDG PET\/CT features for the molecular characterization of primary breast tumors. Eur J Nucl Med Mol Imaging. 2017;44:1945\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1688_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2967\/jnumed.118.223495","volume":"60","author":"CF Uribe","year":"2019","unstructured":"Uribe CF, Mathotaarachchi S, Gaudet V, Smith KC, Rosa-Neto P, B\u00e9nard F, et al. Machine learning in nuclear medicine: part 1-introduction. J Nucl Med. 2019;60:451\u20138.","journal-title":"J Nucl Med"},{"key":"1688_CR14","doi-asserted-by":"publisher","first-page":"17847","DOI":"10.1038\/s41598-019-54371-z","volume":"9","author":"EK Park","year":"2019","unstructured":"Park EK, Lee KS, Seo BK, Cho KR, Woo OH, Son GS, et al. Machine learning approaches to radiogenomics of breast cancer using low-dose perfusion computed tomography: predicting prognostic biomarkers and molecular subtypes. Sci Rep. 2019;9:17847.","journal-title":"Sci Rep"},{"key":"1688_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s10278-019-00179-2","volume":"32","author":"R Haru","year":"2019","unstructured":"Haru R, Mutasa S, Karcich J, Gupta N, Pascual Van Sant E, Nemer J, et al. Predicting breast cancer molecular subtype with MRI dataset utilizing convolutional neural network algorithm. J Digit Imaging. 2019;32:276\u201382.","journal-title":"J Digit Imaging"},{"key":"1688_CR16","doi-asserted-by":"publisher","first-page":"e0234871","DOI":"10.1371\/journal.pone.0234871","volume":"15","author":"A Demircioglu","year":"2020","unstructured":"Demircioglu A, Grueneisen J, Ingenwerth M, Hoffmann O, Pinker-Domenig K, Morris E, et al. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer. PLoS ONE. 2020;15:e0234871.","journal-title":"PLoS ONE"},{"key":"1688_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-018-4984-7","volume":"173","author":"T Wu","year":"2019","unstructured":"Wu T, Sultan LR, Tian J, Cary TW, Sehgal CM. Machine learning for diagnostic ultrasound of triple-negative breast cancer. Breast Cancer Res Treat. 2019;173:365\u201373.","journal-title":"Breast Cancer Res Treat"},{"key":"1688_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.acra.2018.01.023","volume":"26","author":"W Ma","year":"2019","unstructured":"Ma W, Zhao Y, Ji Y, Guo X, Jian X, Liu P, et al. Breast cancer molecular subtype prediction by mammographic radiomic features. Acad Radiol. 2019;26:196\u2013201.","journal-title":"Acad Radiol"},{"key":"1688_CR19","doi-asserted-by":"publisher","first-page":"R224","DOI":"10.1016\/j.cub.2020.01.030","volume":"30","author":"L Maler","year":"2020","unstructured":"Maler L. Neural networks: how a multi-layer network learns to disentangle exogenous from self-generated signals. Curr Biol. 2020;30:R224-224R226.","journal-title":"Curr Biol"},{"key":"1688_CR20","doi-asserted-by":"publisher","first-page":"129268","DOI":"10.1016\/j.chemosphere.2020.129268","volume":"267","author":"SA Naghibi","year":"2021","unstructured":"Naghibi SA, Salehi E, Khajavian M, Vatanpour V, Sillanp\u00e4\u00e4 M. Multivariate data-based optimization of membrane adsorption process for wastewater treatment: multi-layer perceptron adaptive neural network versus adaptive neural fuzzy inference system. Chemosphere. 2021;267:129268.","journal-title":"Chemosphere"},{"key":"1688_CR21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble WS. What is a support vector machine. Nat Biotechnol. 2006;24:1565\u20137.","journal-title":"Nat Biotechnol"},{"key":"1688_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.aca.2020.06.043","volume":"1131","author":"L Blanchet","year":"2020","unstructured":"Blanchet L, Vitale R, van Vorstenbosch R, Stavropoulos G, Pender J, Jonkers D, et al. Constructing bi-plots for random forest: tutorial. Anal Chim Acta. 2020;1131:146\u201355.","journal-title":"Anal Chim Acta"},{"key":"1688_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41419-017-0003-x","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Huang L, Xie D, Zhao Q. EGBMMDA: extreme gradient boosting machine for MiRNA-disease association prediction. Cell Death Dis. 2018;9:3.","journal-title":"Cell Death Dis"},{"key":"1688_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/en10081168","author":"H Zheng","year":"2017","unstructured":"Zheng H, Yuan J, Chen L. Short-term load forecasting using EMD-LSTM neural networks with a Xgboost algorithm for feature importance evaluation. Energies. 2017. https:\/\/doi.org\/10.3390\/en10081168.","journal-title":"Energies"},{"key":"1688_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MNM.0000000000000217","volume":"36","author":"K Kaj\u00e1ry","year":"2015","unstructured":"Kaj\u00e1ry K, T\u0151k\u00e9s T, Dank M, Kulka J, Szak\u00e1ll S Jr, Lengyel Z. Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer. Nucl Med Commun. 2015;36:28\u201337.","journal-title":"Nucl Med Commun"},{"key":"1688_CR26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00259-015-3070-1","volume":"42","author":"K Kitajima","year":"2015","unstructured":"Kitajima K, Fukushima K, Miyoshi Y, Nishimukai A, Hirota S, Igarashi Y, et al. Association between 18F-FDG uptake and molecular subtype of breast cancer. Eur J Nucl Med Mol Imaging. 2015;42:1371\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1688_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s00259-020-04684-3","volume":"47","author":"P Li","year":"2020","unstructured":"Li P, Wang X, Xu C, Liu C, Zheng C, Fulham MJ, et al. 18F-FDG PET\/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients. Eur J Nucl Med Mol Imaging. 2020;47:1116\u201326.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1688_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/RLI.0000000000000518","volume":"54","author":"A Tahmassebi","year":"2019","unstructured":"Tahmassebi A, Wengert GJ, Helbich TH, Bago-Horvath Z, Alaei S, Bartsch R, et al. Impact of machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy and survival outcomes in breast cancer patients. Invest Radiol. 2019;54:110\u20137.","journal-title":"Invest Radiol"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12282-020-01202-z","volume":"28","author":"BI Song","year":"2021","unstructured":"Song BI. A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer. Breast Cancer. 2021;28:664\u201371.","journal-title":"Breast Cancer"},{"key":"1688_CR30","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.1038\/s41598-020-67823-8","volume":"10","author":"H Moghadas-Dastjerdi","year":"2020","unstructured":"Moghadas-Dastjerdi H, Sha-E-Tallat HR, Sannachi L, Sadeghi-Naini A, Czarnota GJ. A priori prediction of tumour response to neoadjuvant chemotherapy in breast cancer patients using quantitative CT and machine learning. Sci Rep. 2020;10:10936.","journal-title":"Sci Rep"},{"key":"1688_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s12149-017-1184-1","volume":"31","author":"L Cheng","year":"2017","unstructured":"Cheng L, Zhang J, Wang Y, Xu X, Zhang Y, Zhang Y, et al. Textural features of (18)F-FDG PET after two cycles of neoadjuvant chemotherapy can predict pCR in patients with locally advanced breast cancer. Ann Nucl Med. 2017;31:544\u201352.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01688-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01688-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T16:52:50Z","timestamp":1644943970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01688-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,30]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01688-3","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,30]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflicts of interest of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by Tianjin Medical University Cancer Hospital Institutional Ethics Committee and conducted in accordance with the Declaration of Helsinki and related ethical guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The written informed consent forms of all the patients involved in the study were waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}